Trial Profile
A Phase II, efficacy trial of CMX-521
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 18 Jun 2018
Price :
$35
*
At a glance
- Drugs CMX-521 (Primary)
- Indications Norovirus infections
- Focus Adverse reactions; Therapeutic Use
- 18 Jun 2018 New trial record
- 12 Jun 2018 According to a Chimerix media release, this trial is expected to initiate in 2019.